Live Attenuated Vaccine for Pig is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus.

The global Live Attenuated Vaccine for Pig market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Live Attenuated Vaccine for Pig is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Live Attenuated Vaccine for Pig is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Live Attenuated Vaccine for Pig include Merck, Pfizer, GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, CSL, KM Biologics and MSD Animal Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccine for Pig, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccine for Pig.

Report Scope

The Live Attenuated Vaccine for Pig market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Live Attenuated Vaccine for Pig market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Live Attenuated Vaccine for Pig manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Live Attenuated Vaccine for Pig Market Report

Report Metric	Details
Report Name	Live Attenuated Vaccine for Pig Market
Segment by Type	Bacterial Vaccines Viral Vaccines
Segment by Application	Piglet Adult Pig
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Pfizer, GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, CSL, KM Biologics, MSD Animal Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Attenuated Vaccine for Pig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Attenuated Vaccine for Pig in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Live Attenuated Vaccine for Pig Market report?

Ans: The main players in the Live Attenuated Vaccine for Pig Market are Merck, Pfizer, GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, CSL, KM Biologics, MSD Animal Health

What are the Application segmentation covered in the Live Attenuated Vaccine for Pig Market report?

Ans: The Applications covered in the Live Attenuated Vaccine for Pig Market report are Piglet, Adult Pig

What are the Type segmentation covered in the Live Attenuated Vaccine for Pig Market report?

Ans: The Types covered in the Live Attenuated Vaccine for Pig Market report are Bacterial Vaccines, Viral Vaccines

1 Live Attenuated Vaccine for Pig Market Overview

1.1 Product Overview and Scope of Live Attenuated Vaccine for Pig

1.2 Live Attenuated Vaccine for Pig Segment by Type

1.2.1 Global Live Attenuated Vaccine for Pig Market Value Comparison by Type (2024-2030)

1.2.2 Bacterial Vaccines

1.2.3 Viral Vaccines

1.3 Live Attenuated Vaccine for Pig Segment by Application

1.3.1 Global Live Attenuated Vaccine for Pig Market Value by Application: (2024-2030)

1.3.2 Piglet

1.3.3 Adult Pig

1.4 Global Live Attenuated Vaccine for Pig Market Size Estimates and Forecasts

1.4.1 Global Live Attenuated Vaccine for Pig Revenue 2019-2030

1.4.2 Global Live Attenuated Vaccine for Pig Sales 2019-2030

1.4.3 Global Live Attenuated Vaccine for Pig Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Live Attenuated Vaccine for Pig Market Competition by Manufacturers

2.1 Global Live Attenuated Vaccine for Pig Sales Market Share by Manufacturers (2019-2024)

2.2 Global Live Attenuated Vaccine for Pig Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Live Attenuated Vaccine for Pig Average Price by Manufacturers (2019-2024)

2.4 Global Live Attenuated Vaccine for Pig Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Live Attenuated Vaccine for Pig, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Live Attenuated Vaccine for Pig, Product Type & Application

2.7 Live Attenuated Vaccine for Pig Market Competitive Situation and Trends

2.7.1 Live Attenuated Vaccine for Pig Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Live Attenuated Vaccine for Pig Players Market Share by Revenue

2.7.3 Global Live Attenuated Vaccine for Pig Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Live Attenuated Vaccine for Pig Retrospective Market Scenario by Region

3.1 Global Live Attenuated Vaccine for Pig Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Live Attenuated Vaccine for Pig Global Live Attenuated Vaccine for Pig Sales by Region: 2019-2030

3.2.1 Global Live Attenuated Vaccine for Pig Sales by Region: 2019-2024

3.2.2 Global Live Attenuated Vaccine for Pig Sales by Region: 2025-2030

3.3 Global Live Attenuated Vaccine for Pig Global Live Attenuated Vaccine for Pig Revenue by Region: 2019-2030

3.3.1 Global Live Attenuated Vaccine for Pig Revenue by Region: 2019-2024

3.3.2 Global Live Attenuated Vaccine for Pig Revenue by Region: 2025-2030

3.4 North America Live Attenuated Vaccine for Pig Market Facts & Figures by Country

3.4.1 North America Live Attenuated Vaccine for Pig Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Live Attenuated Vaccine for Pig Sales by Country (2019-2030)

3.4.3 North America Live Attenuated Vaccine for Pig Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Live Attenuated Vaccine for Pig Market Facts & Figures by Country

3.5.1 Europe Live Attenuated Vaccine for Pig Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Live Attenuated Vaccine for Pig Sales by Country (2019-2030)

3.5.3 Europe Live Attenuated Vaccine for Pig Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Live Attenuated Vaccine for Pig Market Facts & Figures by Country

3.6.1 Asia Pacific Live Attenuated Vaccine for Pig Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Live Attenuated Vaccine for Pig Sales by Country (2019-2030)

3.6.3 Asia Pacific Live Attenuated Vaccine for Pig Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Live Attenuated Vaccine for Pig Market Facts & Figures by Country

3.7.1 Latin America Live Attenuated Vaccine for Pig Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Live Attenuated Vaccine for Pig Sales by Country (2019-2030)

3.7.3 Latin America Live Attenuated Vaccine for Pig Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Live Attenuated Vaccine for Pig Market Facts & Figures by Country

3.8.1 Middle East and Africa Live Attenuated Vaccine for Pig Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Live Attenuated Vaccine for Pig Sales by Country (2019-2030)

3.8.3 Middle East and Africa Live Attenuated Vaccine for Pig Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Live Attenuated Vaccine for Pig Sales by Type (2019-2030)

4.1.1 Global Live Attenuated Vaccine for Pig Sales by Type (2019-2024)

4.1.2 Global Live Attenuated Vaccine for Pig Sales by Type (2025-2030)

4.1.3 Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2019-2030)

4.2 Global Live Attenuated Vaccine for Pig Revenue by Type (2019-2030)

4.2.1 Global Live Attenuated Vaccine for Pig Revenue by Type (2019-2024)

4.2.2 Global Live Attenuated Vaccine for Pig Revenue by Type (2025-2030)

4.2.3 Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2019-2030)

4.3 Global Live Attenuated Vaccine for Pig Price by Type (2019-2030)

5 Segment by Application

5.1 Global Live Attenuated Vaccine for Pig Sales by Application (2019-2030)

5.1.1 Global Live Attenuated Vaccine for Pig Sales by Application (2019-2024)

5.1.2 Global Live Attenuated Vaccine for Pig Sales by Application (2025-2030)

5.1.3 Global Live Attenuated Vaccine for Pig Sales Market Share by Application (2019-2030)

5.2 Global Live Attenuated Vaccine for Pig Revenue by Application (2019-2030)

5.2.1 Global Live Attenuated Vaccine for Pig Revenue by Application (2019-2024)

5.2.2 Global Live Attenuated Vaccine for Pig Revenue by Application (2025-2030)

5.2.3 Global Live Attenuated Vaccine for Pig Revenue Market Share by Application (2019-2030)

5.3 Global Live Attenuated Vaccine for Pig Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Live Attenuated Vaccine for Pig Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Live Attenuated Vaccine for Pig Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 GlaxoSmithKline

6.3.1 GlaxoSmithKline Corporation Information

6.3.2 GlaxoSmithKline Description and Business Overview

6.3.3 GlaxoSmithKline Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GlaxoSmithKline Live Attenuated Vaccine for Pig Product Portfolio

6.3.5 GlaxoSmithKline Recent Developments/Updates

6.4 Astellas Pharma

6.4.1 Astellas Pharma Corporation Information

6.4.2 Astellas Pharma Description and Business Overview

6.4.3 Astellas Pharma Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Astellas Pharma Live Attenuated Vaccine for Pig Product Portfolio

6.4.5 Astellas Pharma Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Corporation Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Johnson & Johnson Live Attenuated Vaccine for Pig Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

6.6 CSL

6.6.1 CSL Corporation Information

6.6.2 CSL Description and Business Overview

6.6.3 CSL Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.6.4 CSL Live Attenuated Vaccine for Pig Product Portfolio

6.6.5 CSL Recent Developments/Updates

6.7 KM Biologics

6.6.1 KM Biologics Corporation Information

6.6.2 KM Biologics Description and Business Overview

6.6.3 KM Biologics Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.4.4 KM Biologics Live Attenuated Vaccine for Pig Product Portfolio

6.7.5 KM Biologics Recent Developments/Updates

6.8 MSD Animal Health

6.8.1 MSD Animal Health Corporation Information

6.8.2 MSD Animal Health Description and Business Overview

6.8.3 MSD Animal Health Live Attenuated Vaccine for Pig Sales, Revenue and Gross Margin (2019-2024)

6.8.4 MSD Animal Health Live Attenuated Vaccine for Pig Product Portfolio

6.8.5 MSD Animal Health Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Live Attenuated Vaccine for Pig Industry Chain Analysis

7.2 Live Attenuated Vaccine for Pig Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Live Attenuated Vaccine for Pig Production Mode & Process

7.4 Live Attenuated Vaccine for Pig Sales and Marketing

7.4.1 Live Attenuated Vaccine for Pig Sales Channels

7.4.2 Live Attenuated Vaccine for Pig Distributors

7.5 Live Attenuated Vaccine for Pig Customers

8 Live Attenuated Vaccine for Pig Market Dynamics

8.1 Live Attenuated Vaccine for Pig Industry Trends

8.2 Live Attenuated Vaccine for Pig Market Drivers

8.3 Live Attenuated Vaccine for Pig Market Challenges

8.4 Live Attenuated Vaccine for Pig Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Live Attenuated Vaccine for Pig Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Live Attenuated Vaccine for Pig Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Live Attenuated Vaccine for Pig Market Competitive Situation by Manufacturers in 2023

Table 4. Global Live Attenuated Vaccine for Pig Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Live Attenuated Vaccine for Pig Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Live Attenuated Vaccine for Pig Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Live Attenuated Vaccine for Pig Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Live Attenuated Vaccine for Pig Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Live Attenuated Vaccine for Pig, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Live Attenuated Vaccine for Pig, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Live Attenuated Vaccine for Pig, Product Type & Application

Table 12. Global Key Manufacturers of Live Attenuated Vaccine for Pig, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Live Attenuated Vaccine for Pig by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccine for Pig as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Live Attenuated Vaccine for Pig Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Live Attenuated Vaccine for Pig Sales by Region (2019-2024) & (Units)

Table 18. Global Live Attenuated Vaccine for Pig Sales Market Share by Region (2019-2024)

Table 19. Global Live Attenuated Vaccine for Pig Sales by Region (2025-2030) & (Units)

Table 20. Global Live Attenuated Vaccine for Pig Sales Market Share by Region (2025-2030)

Table 21. Global Live Attenuated Vaccine for Pig Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Live Attenuated Vaccine for Pig Revenue Market Share by Region (2019-2024)

Table 23. Global Live Attenuated Vaccine for Pig Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Live Attenuated Vaccine for Pig Revenue Market Share by Region (2025-2030)

Table 25. North America Live Attenuated Vaccine for Pig Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Live Attenuated Vaccine for Pig Sales by Country (2019-2024) & (Units)

Table 27. North America Live Attenuated Vaccine for Pig Sales by Country (2025-2030) & (Units)

Table 28. North America Live Attenuated Vaccine for Pig Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Live Attenuated Vaccine for Pig Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Live Attenuated Vaccine for Pig Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Live Attenuated Vaccine for Pig Sales by Country (2019-2024) & (Units)

Table 32. Europe Live Attenuated Vaccine for Pig Sales by Country (2025-2030) & (Units)

Table 33. Europe Live Attenuated Vaccine for Pig Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Live Attenuated Vaccine for Pig Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Live Attenuated Vaccine for Pig Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Live Attenuated Vaccine for Pig Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Live Attenuated Vaccine for Pig Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Live Attenuated Vaccine for Pig Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Live Attenuated Vaccine for Pig Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Live Attenuated Vaccine for Pig Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Live Attenuated Vaccine for Pig Sales by Country (2019-2024) & (Units)

Table 42. Latin America Live Attenuated Vaccine for Pig Sales by Country (2025-2030) & (Units)

Table 43. Latin America Live Attenuated Vaccine for Pig Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Live Attenuated Vaccine for Pig Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Live Attenuated Vaccine for Pig Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Live Attenuated Vaccine for Pig Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Live Attenuated Vaccine for Pig Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Live Attenuated Vaccine for Pig Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Live Attenuated Vaccine for Pig Sales (Units) by Type (2019-2024)

Table 51. Global Live Attenuated Vaccine for Pig Sales (Units) by Type (2025-2030)

Table 52. Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2019-2024)

Table 53. Global Live Attenuated Vaccine for Pig Sales Market Share by Type (2025-2030)

Table 54. Global Live Attenuated Vaccine for Pig Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Live Attenuated Vaccine for Pig Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2019-2024)

Table 57. Global Live Attenuated Vaccine for Pig Revenue Market Share by Type (2025-2030)

Table 58. Global Live Attenuated Vaccine for Pig Price (US$/Unit) by Type (2019-2024)

Table 59. Global Live Attenuated Vaccine for Pig Price (US$/Unit) by Type (2025-2030)

Table 60. Global Live Attenuated Vaccine for Pig Sales (Units) by Application (2019-2024)

Table 61. Global Live Attenuated Vaccine for Pig Sales (Units) by Application (2025-2030)

Table 62. Global Live Attenuated Vaccine for Pig Sales Market Share by Application (2019-2024)

Table 63. Global Live Attenuated Vaccine for Pig Sales Market Share by Application (2025-2030)

Table 64. Global Live Attenuated Vaccine for Pig Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Live Attenuated Vaccine for Pig Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Live Attenuated Vaccine for Pig Revenue Market Share by Application (2019-2024)

Table 67. Global Live Attenuated Vaccine for Pig Revenue Market Share by Application (2025-2030)

Table 68. Global Live Attenuated Vaccine for Pig Price (US$/Unit) by Application (2019-2024)

Table 69. Global Live Attenuated Vaccine for Pig Price (US$/Unit) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Merck Live Attenuated Vaccine for Pig Product

Table 74. Merck Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer Live Attenuated Vaccine for Pig Product

Table 79. Pfizer Recent Developments/Updates

Table 80. GlaxoSmithKline Corporation Information

Table 81. GlaxoSmithKline Description and Business Overview

Table 82. GlaxoSmithKline Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. GlaxoSmithKline Live Attenuated Vaccine for Pig Product

Table 84. GlaxoSmithKline Recent Developments/Updates

Table 85. Astellas Pharma Corporation Information

Table 86. Astellas Pharma Description and Business Overview

Table 87. Astellas Pharma Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Astellas Pharma Live Attenuated Vaccine for Pig Product

Table 89. Astellas Pharma Recent Developments/Updates

Table 90. Johnson & Johnson Corporation Information

Table 91. Johnson & Johnson Description and Business Overview

Table 92. Johnson & Johnson Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Johnson & Johnson Live Attenuated Vaccine for Pig Product

Table 94. Johnson & Johnson Recent Developments/Updates

Table 95. CSL Corporation Information

Table 96. CSL Description and Business Overview

Table 97. CSL Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. CSL Live Attenuated Vaccine for Pig Product

Table 99. CSL Recent Developments/Updates

Table 100. KM Biologics Corporation Information

Table 101. KM Biologics Description and Business Overview

Table 102. KM Biologics Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. KM Biologics Live Attenuated Vaccine for Pig Product

Table 104. KM Biologics Recent Developments/Updates

Table 105. MSD Animal Health Corporation Information

Table 106. MSD Animal Health Description and Business Overview

Table 107. MSD Animal Health Live Attenuated Vaccine for Pig Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. MSD Animal Health Live Attenuated Vaccine for Pig Product

Table 109. MSD Animal Health Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Live Attenuated Vaccine for Pig Distributors List

Table 113. Live Attenuated Vaccine for Pig Customers List

Table 114. Live Attenuated Vaccine for Pig Market Trends

Table 115. Live Attenuated Vaccine for Pig Market Drivers

Table 116. Live Attenuated Vaccine for Pig Market Challenges

Table 117. Live Attenuated Vaccine for Pig Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Live Attenuated Vaccine for Pig

Figure 2. Global Live Attenuated Vaccine for Pig Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Live Attenuated Vaccine for Pig Market Share by Type in 2023 & 2030

Figure 4. Bacterial Vaccines Product Picture

Figure 5. Viral Vaccines Product Picture

Figure 6. Global Live Attenuated Vaccine for Pig Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Live Attenuated Vaccine for Pig Market Share by Application in 2023 & 2030

Figure 8. Piglet

Figure 9. Adult Pig

Figure 10. Global Live Attenuated Vaccine for Pig Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Live Attenuated Vaccine for Pig Market Size (2019-2030) & (US$ Million)

Figure 12. Global Live Attenuated Vaccine for Pig Sales (2019-2030) & (Units)

Figure 13. Global Live Attenuated Vaccine for Pig Average Price (US$/Unit) & (2019-2030)

Figure 14. Live Attenuated Vaccine for Pig Report Years Considered

Figure 15. Live Attenuated Vaccine for Pig Sales Share by Manufacturers in 2023

Figure 16. Global Live Attenuated Vaccine for Pig Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Live Attenuated Vaccine for Pig Players: Market Share by Revenue in 2023

Figure 18. Live Attenuated Vaccine for Pig Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Live Attenuated Vaccine for Pig Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Live Attenuated Vaccine for Pig Sales Market Share by Country (2019-2030)

Figure 21. North America Live Attenuated Vaccine for Pig Revenue Market Share by Country (2019-2030)

Figure 22. United States Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Live Attenuated Vaccine for Pig Sales Market Share by Country (2019-2030)

Figure 25. Europe Live Attenuated Vaccine for Pig Revenue Market Share by Country (2019-2030)

Figure 26. Germany Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Live Attenuated Vaccine for Pig Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Live Attenuated Vaccine for Pig Revenue Market Share by Region (2019-2030)

Figure 33. China Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Live Attenuated Vaccine for Pig Sales Market Share by Country (2019-2030)

Figure 41. Latin America Live Attenuated Vaccine for Pig Revenue Market Share by Country (2019-2030)

Figure 42. Mexico Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Live Attenuated Vaccine for Pig Sales Market Share by Country (2019-2030)

Figure 46. Middle East & Africa Live Attenuated Vaccine for Pig Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Live Attenuated Vaccine for Pig Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Live Attenuated Vaccine for Pig by Type (2019-2030)

Figure 51. Global Revenue Market Share of Live Attenuated Vaccine for Pig by Type (2019-2030)

Figure 52. Global Live Attenuated Vaccine for Pig Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Live Attenuated Vaccine for Pig by Application (2019-2030)

Figure 54. Global Revenue Market Share of Live Attenuated Vaccine for Pig by Application (2019-2030)

Figure 55. Global Live Attenuated Vaccine for Pig Price (US$/Unit) by Application (2019-2030)

Figure 56. Live Attenuated Vaccine for Pig Value Chain

Figure 57. Live Attenuated Vaccine for Pig Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions